This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Dec 12;352(9144):1933; author reply 1934.

doi: 10.1016/s0140-6736(05)60424-2.

The UK Prospective Diabetes Study

PMID: 9863809
DOI: 10.1016/s0140-6736(05)60424-2

Comment

The UK Prospective Diabetes Study

P B Fowler. Lancet. 1998.

. 1998 Dec 12;352(9144):1933; author reply 1934.

doi: 10.1016/s0140-6736(05)60424-2.

Author

PMID: 9863809
DOI: 10.1016/s0140-6736(05)60424-2

No abstract available

PubMed Disclaimer

Comment on

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 12;352(9131):837-53. Lancet. 1998. PMID: 9742976 Clinical Trial.
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
[No authors listed] [No authors listed] Lancet. 1998 Sep 12;352(9131):854-65. Lancet. 1998. PMID: 9742977 Clinical Trial.

Similar articles

The UK Prospective Diabetes Study.
de Fine Olivarius N, Andreasen AH. de Fine Olivarius N, et al. Lancet. 1998 Dec 12;352(9144):1933; author reply 1934. doi: 10.1016/s0140-6736(05)60423-0. Lancet. 1998. PMID: 9863808 No abstract available.
The UK Prospective Diabetes Study.
Good CB. Good CB. Lancet. 1998 Dec 12;352(9144):1933; author reply 1934. doi: 10.1016/s0140-6736(05)60425-4. Lancet. 1998. PMID: 9863810 No abstract available.
The UK Prospective Diabetes Study.
Evans M. Evans M. Lancet. 1998 Dec 12;352(9144):1932-3; author reply 1934. doi: 10.1016/S0140-6736(05)60422-9. Lancet. 1998. PMID: 9863807 No abstract available.
How to prescribe hypoglycaemic agents.
Tasker PR. Tasker PR. Practitioner. 2002 Apr;246(1633):236, 241-3, 245 passim. Practitioner. 2002. PMID: 11961990 Review. No abstract available.
[More active therapy in diabetes type 2 is justified by findings in a break-through study. 20-year follow-up of over 5000 patients].
Nilsson P, Attvall S, Eliasson M. Nilsson P, et al. Lakartidningen. 1998 Nov 4;95(45):4983-4, 4987. Lakartidningen. 1998. PMID: 9835711 Review. Swedish. No abstract available.

See all similar articles

Cited by

Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy.
Prior JO, Monbaron D, Koehli M, Calcagni ML, Ruiz J, Bischof Delaloye A. Prior JO, et al. Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):60-9. doi: 10.1007/s00259-004-1591-0. Epub 2004 Aug 10. Eur J Nucl Med Mol Imaging. 2005. PMID: 15309331 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information